Calcium phosphate nanocoatings and nanocomposites, part 2: Thin films for slow drug delivery and osteomyelitis

Ben-Nissan, B; Macha, I; Cazalbou, S; Choi, AH

Calcium phosphate nanocoatings and nanocomposites, part 2: Thin films for slow drug delivery and osteomyelitis

Ben-Nissan, B Macha, I

Cazalbou, S Choi, AH

Permalink

Publication Type:: Journal Article
Citation:: Nanomedicine, 2016, 11 (5), pp. 531 - 544
Issue Date:: 2016-03-01

Closed Access

	Filename	Description	Size
	Calcium phosphate nanocoatings and nanocomposites%2c part 2 thin films for slow drug delivery and osteomyelitis.pdf	Published Version	5.61 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Ben-Nissan, B	en_US
dc.contributor.author	Macha, I https://orcid.org/0000-0002-7517-4537	en_US
dc.contributor.author	Cazalbou, S	en_US
dc.contributor.author	Choi, AH	en_US
dc.date.issued	2016-03-01	en_US
dc.identifier.citation	Nanomedicine, 2016, 11 (5), pp. 531 - 544	en_US
dc.identifier.issn	1743-5889	en_US
dc.identifier.uri	http://hdl.handle.net/10453/97239
dc.description.abstract	© 2016 Future Medicine Ltd. During the last two decades although many calcium phosphate based nanomaterials have been proposed for both drug delivery, and bone regeneration, their coating applications have been somehow slow due to the problems related to their complicated synthesis methods. In order to control the efficiency of local drug delivery of a biomaterial the critical pore sizes as well as good control of the chemical composition is pertinent. A variety of calcium phosphate based nanocoated composite drug delivery systems are currently being investigated. This review aims to give an update into the advancements of calcium phosphate nanocoatings and thin film nanolaminates. In particular recent research on PLA/hydroxyapatite composite thin films and coatings into the slow drug delivery for the possible treatment of osteomyelitis is covered.	en_US
dc.relation.ispartof	Nanomedicine	en_US
dc.relation.isbasedon	10.2217/nnm.15.220	en_US
dc.subject.classification	Nanoscience & Nanotechnology	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Osteomyelitis	en_US
dc.subject.mesh	Calcium Phosphates	en_US
dc.subject.mesh	Durapatite	en_US
dc.subject.mesh	Coated Materials, Biocompatible	en_US
dc.subject.mesh	Drug Delivery Systems	en_US
dc.subject.mesh	Bone Regeneration	en_US
dc.subject.mesh	Nanocomposites	en_US
dc.title	Calcium phosphate nanocoatings and nanocomposites, part 2: Thin films for slow drug delivery and osteomyelitis	en_US
dc.type	Journal Article
utslib.citation.volume	5	en_US
utslib.citation.volume	11	en_US
utslib.for	1007 Nanotechnology	en_US
utslib.for	1004 Medical Biotechnology	en_US
utslib.for	0306 Physical Chemistry (incl. Structural)	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
utslib.copyright.status	closed_access
pubs.issue	5	en_US
pubs.publication-status	Published	en_US
pubs.volume	11	en_US

Abstract:

© 2016 Future Medicine Ltd. During the last two decades although many calcium phosphate based nanomaterials have been proposed for both drug delivery, and bone regeneration, their coating applications have been somehow slow due to the problems related to their complicated synthesis methods. In order to control the efficiency of local drug delivery of a biomaterial the critical pore sizes as well as good control of the chemical composition is pertinent. A variety of calcium phosphate based nanocoated composite drug delivery systems are currently being investigated. This review aims to give an update into the advancements of calcium phosphate nanocoatings and thin film nanolaminates. In particular recent research on PLA/hydroxyapatite composite thin films and coatings into the slow drug delivery for the possible treatment of osteomyelitis is covered.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/97239